首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1542458

全球生物可吸收支架市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Bioabsorbable Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球生物可吸收支架市场需求预计将从2023年的4.6022亿美元达到近8.3407亿美元的市场规模，2024-2032年研究期间复合年增长率为6.83%。

生物可吸收支架插入人体血管以防止或减轻阻塞，并在适当的时候被人体吸收或溶解。理想的支架应具有优异的机械性能，以在所需的时间内提供必要的血管支撑。它必须具有生物相容性，具有良好的递送能力以携带抗增殖药物以减少再狭窄，并且具有足够的降解时间。经过一段特定的时间后，支架会透过重建血管的正常形态和生理学（运动性、血管几何形状和剪切应力）而消失，而不会产生强烈的发炎反应。支架的成功很大程度取决于材料的选择和设计。可吸收支架是介入性心臟病学领域最有前途的器材之一。

市场动态

心血管疾病的高盛行率和全球人口对微创手术的偏好增加将是生物可吸收支架市场成长的关键趋势因素。高可支配收入和对技术先进的治疗方法的偏好将促进市场成长。使用这些支架透过减少患者血栓形成的机会和双重抗血小板治疗来提高治疗效率将是市场的助推器。老年人口的增加以及由于不健康的生活方式而导致的冠状动脉疾病风险的增加将有利于市场的成长。与该技术开发相关的巨额投资以及支架植入术对人体的不良影响将是该市场成长的主要障碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球生物可吸收支架市场的各个细分市场进行了包容性评估。生物可吸收支架产业的成长和趋势为本研究提供了整体方法。

市场区隔

生物可吸收支架市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

透过生物材料

生物可吸收聚合物支架
生物可吸收金属支架

按申请

冠状动脉疾病
週边动脉疾病

按吸收率

分段吸收速度慢
吸收速度快

按最终用户

医院
心臟中心
门诊手术中心

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的生物可吸收支架市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物可吸收支架市场的主要参与者包括 Amaranth Medical、Arterial Remodeling Technologies、Arterius Limited、B.Braun Melsungen AG、Biotronik SE & Co. KG、Boston Scientific Corporation、Elixir Medical Corporation、Kyoto Medical Planning Co. Ltd、Microport Scientific公司、Reva Medical、Terumo Corporation。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 生物材料的市场吸引力分析
- 市场吸引力分析：依应用分类
- 以吸收率分析市场吸引力
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球生物可吸收支架市场分析：依生物材料

生物材料概述
历史和预测数据
生物材料分析
生物可吸收聚合物支架
生物可吸收金属支架

第 6 章：全球生物可吸收支架市场分析：依应用分类

概述：按应用
历史和预测数据
分析：按应用
冠状动脉疾病
週边动脉疾病

第 7 章：全球生物可吸收支架市场分析：依吸收率

按吸收率概述
历史和预测数据
按吸收率分析
分段吸收速度慢
吸收速度快

第 8 章：全球生物可吸收支架市场分析：依最终用户分类

最终用户概述
历史和预测数据
最终用户分析
医院
心臟中心
门诊手术中心

第 9 章：全球生物可吸收支架市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：生物可吸收支架公司的竞争格局

生物可吸收支架市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Amaranth Medical

公司概况
公司收入
产品
最新动态

Arterial Remodeling Technologies

公司概况
公司收入
产品
最新动态

Arterius Limited

公司概况
公司收入
产品
最新动态

B.Braun Melsungen AG

公司概况
公司收入
产品
最新动态

Biotronik SE & Co. KG

公司概况
公司收入
产品
最新动态

Boston Scientific Corporation

公司概况
公司收入
产品
最新动态

Elixir Medical Corporation

公司概况
公司收入
产品
最新动态

Kyoto Medical Planning Co. Ltd.

公司概况
公司收入
产品
最新动态

Microport Scientific Corporation

公司概况
公司收入
产品
最新动态

Reva Medical

公司概况
公司收入
产品
最新动态

Terumo Corporation

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213618

The global demand for Bioabsorbable Stents Market is presumed to reach the market size of nearly USD 834.07 Million by 2032 from USD 460.22 Million in 2023 with a CAGR of 6.83% under the study period 2024-2032.

Bioabsorbable stents are inserted into a human blood vessel to prevent or alleviate a blockage and are absorbed or dissolved by the body in due course. An ideal stent should have superior mechanical properties to provide the necessary vessel support during the required period. It must be biocompatible, have good deliverability to carry an antiproliferative drug to reduce restenosis, and have adequate degradation time. After a specific period, the stent disappears by re-establishing the normal morphology and physiology (motility, vessel geometry, and shear stress) of the blood vessel without creating an intense inflammatory response. The success of a stent largely depends on the selection of the material and the design. Absorbable stents are one of the most promising devices in the field of interventional cardiology.

MARKET DYNAMICS

High prevalence of cardiovascular disorders and increased preference for minimally invasive procedures among the global population will be the critical trending factors for the growth of the bioabsorbable stents market. High disposable income and inclination toward technologically advanced treatment methods will boost market growth. The increased efficiency of the treatment using these stents by reducing the chances of thrombosis and dual antiplatelet therapy among patients will be a market booster. The increasing geriatric population and the increased risk of coronary artery diseases due to unhealthy lifestyles will benefit market growth. The massive investments associated with this technology's development and the undesirable effects of stenting in the human body will be the major hurdles for this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioabsorbable Stents. The growth and trends of Bioabsorbable Stents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Bioabsorbable Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Biomaterial

Bioabsorbable Polymer-based Stents
Bioabsorbable Metallic Stents

By Application

Coronary Artery Disease
Peripheral Artery Disease

By Absorption Rate

Segmentation Slow Absorption Rate
Fast Absorption Rate

By End-user

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Bioabsorbable Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioabsorbable Stents market include Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B.Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Microport Scientific Corporation, Reva Medical, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOABSORBABLE STENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Biomaterial
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Absorption Rate
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY BIOMATERIAL

5.1. Overview By Biomaterial
5.2. Historical and Forecast Data
5.3. Analysis By Biomaterial
5.4. Bioabsorbable Polymer-based Stents Historic and Forecast Sales By Regions
5.5. Bioabsorbable Metallic Stents Historic and Forecast Sales By Regions

6. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Coronary Artery Disease Historic and Forecast Sales By Regions
6.5. Peripheral Artery Disease Historic and Forecast Sales By Regions

7. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY ABSORPTION RATE

7.1. Overview By Absorption Rate
7.2. Historical and Forecast Data
7.3. Analysis By Absorption Rate
7.4. Segmentation Slow Absorption Rate Historic and Forecast Sales By Regions
7.5. Fast Absorption Rate Historic and Forecast Sales By Regions

8. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data
8.3. Analysis By End-user
8.4. Hospitals Historic and Forecast Sales By Regions
8.5. Cardiac Centers Historic and Forecast Sales By Regions
8.6. Ambulatory Surgical Centers Historic and Forecast Sales By Regions

9. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BIOABSORBABLE STENTS COMPANIES

10.1. Bioabsorbable Stents Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF BIOABSORBABLE STENTS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Amaranth Medical
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Arterial Remodeling Technologies
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Arterius Limited
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. B.Braun Melsungen AG
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Biotronik SE & Co. KG
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boston Scientific Corporation
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Elixir Medical Corporation
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Kyoto Medical Planning Co. Ltd.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Microport Scientific Corporation
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Reva Medical
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Terumo Corporation
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments